Study of Opioid-Induced Constipation 1 Project
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Cancer
Related studies linked through entity extraction aliases.
Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
- Status
- UNKNOWN
- Phase
- NA
Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Calm for Cancer Sleep Disturbance
- Status
- COMPLETED
- Phase
- NA
UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2
An Evaluation of the Families Addressing Cancer Together (FACT) Intervention
- Status
- COMPLETED
- Phase
- NA
Impact of the Therapeutic Alliance on Reduction of Disparities in Latino End-of-Life Cancer Care
- Status
- COMPLETED
- Phase
- N/A
ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling
- Status
- RECRUITING
- Phase
- PHASE2
Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
- Status
- COMPLETED
- Phase
- NA
Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Impact of the Coronavirus (COVID-19) on Patients With Cancer
- Status
- RECRUITING
- Phase
- N/A
Personalized Exercise Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Myelodysplastic Syndrome and Acute Myeloid Leukemia Related to PARP Inhibitors (MyeloRIB)
- Status
- COMPLETED
- Phase
- N/A
AMPLE-3: IPC Plus Talc vs VATS in Management of Malignant Pleural Effusion
- Status
- COMPLETED
- Phase
- NA
Vopratelimab (JTX-2011) Alone and in Combination With Anti-Programmed Cell Death Protein 1 (PD-1) or Anti-Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) in Subjects With Advanced and/or Refractory Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
MOST EMPOWER: Optimizing An Emotion Regulation Intervention
- Status
- COMPLETED
- Phase
- NA